Device for treating diabetes and methods thereof

Details Device for treating diabetes and methods thereof Device for treating diabetes and methods thereof

2006-06-12

2008-10-07

Landsman, Robert (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021800, C424S423000

Reexamination Certificate

active

07432241

ABSTRACT:
A composite supported vascular graft comprising Vascular Endothelial Growth Factor (VEGF) and/or Platelet Derived Growth Factor (PDGF) for enhanced site-specific angiogenesis and methods thereof are disclosed. At least one VEGF, PDGF or angiogenesis factor is incorporated into the composite vascular graft to facilitate enhanced angiogenesis so as the cells are stimulated to migrate to environments having higher concentration of growth factors and start mitosis.

REFERENCES:
patent: 6387663 (2002-05-01), Hall et al.
patent: 6391052 (2002-05-01), Buirge et al.
patent: 6395023 (2002-05-01), Summers
patent: 6451047 (2002-09-01), McCrea et al.
patent: 6752826 (2004-06-01), Holloway et al.
patent: 7000305 (2006-02-01), Jayaraman
patent: 7037332 (2006-05-01), Kutryk et al.

Affiliated with

Also associated with

Rating

Device for treating diabetes and methods thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Device for treating diabetes and methods thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for treating diabetes and methods thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3999125